Dr. Piu Chan is well known for his translational research on neurodegenerative disorders and other age-related disorders. Collaborating with Dr. Carlie Tanner on several unique cohorts, they were the first to report that environmental exposures are a major risk factor for Parkinson’s disease (PD). He has worked on developing preclinical models for CNS diseases, including PD and dyskinesia. He has studied susceptibility genes and a variety of biomarkers for PD and Alzheimer's disease in a few unique cohorts in China, studies aimed at predicting and preventing neurodegenerative diseases. Dr. Chan is the committee member for the MDS “task force on the definition of Parkinson’s disease” and “telemedicine task force.” Dr. Chan’s team has participated in the International LRRK2 Consortium and Apple’s mPower projects. Dr. Chan has published more than 240 SCI peer-reviewed papers and about 350 peer-reviewed papers and served as editorial member of more than 15 international journals.